Slide 1: ODDITY
Slide 2: Disclaimer
DISCLAIMER This presentation contains estimates and other statistical data made by independent parties and by the Company relating to market size and the concentration of our voting power as a result of our dual class structure; our status as a foreign private issuer; and other risk factors set grow
Slide 3: Our vision is to transform the global beauty & wellness market
OUR VISION IS TO TRANSFORM THE GLOBAL BEAUTY & WELLNESS MARKET THROUGH ISRAELI TECHNOLOGY & ENTREPRENEURIAL THINKING FOR THE BENEFIT OF CONSUMERS ALL OVER THE WORLD. 3
Slide 4: Our technology platform supports a portfolio of powerhouse brands
OUR TECHNOLOGY PLATFORM SUPPORTS A PORTFOLIO OF POWERHOUSE BRANDS 4
Slide 5: $ODD Financial Highlights
$ODD FINANCIAL HIGHLIGHTS $781M $166M $793M Net revenue, Adjusted EBITDA1, Cash, cash equivalents, LTM Q325 LTM Q325 & investments4 +26% 21% $105M YoY net revenue Adjusted EBITDA Free cash flow3, growth, LTM Q325 margin2, LTM Q325 LTM Q325 Note: 1. Adjusted EBITDA is a supplemental measure of our pe
Slide 6: A rare combination of scale + growth + profitability
A RARE COMBINATION OF SCALE + GROWTH + PROFITABILITY +24-25% +27% NET REVENUE GROWTH1 +57% +46% $806-809 +101% $647 $509 $325 NET REVENUE ($M) $223 $150 $161-163 $107 $27 $39 ADJUSTED EBITDA2 ($M) FY21 FY22 FY23 FY24 FY25E Note: 1. Percentages reflect year-over-year growth rates for the same period
Slide 7: Q3 results exceeded guidance
Q3 RESULTS EXCEEDED GUIDANCE Q3 2025 ACTUAL GUIDANCE NET REVENUE GROWTH1 24% 21 to 23% GROSS MARGIN 71.6% 68% ADJUSTED EBITDA2 $29mn $26mn to $28mn ADJUSTED DILUTED EPS3 $0.40 $0.33 to 0.36 Note: 1. Percentages reflect year-over-year growth rates for the same period of the prior year. 2. Adjusted EB
Slide 8: FY 2025 Financial Outlook
FY 2025 FINANCIAL OUTLOOK GUIDANCE PRIOR FY 2025 FY 2025 FY 2025 FY 2025 Current August April February NET REVENUE1 24 to 25% 23 to 24% 22 to 23% 20 to 21% %/$ $806 to 809mn $799 to 804mn $790 to 798mn $776 to 785mn GROSS MARGIN 72.5% 71.0% 71.0% 70.0% ADJUSTED EBITDA2 $161 to 163mn $160mn to 162mn
Slide 9: Q3 2025 Highlights
Q3 2025 HIGHLIGHTS Q3 2025 vs Q3 2024 Net Revenue $148M +24% Gross Margin 71.6% +170 bps Adjusted EBITDA $29M +16% 1 Adjusted EBITDA margin 19.5% -140 bps 2 Adjusted Diluted EPS $0.40 +24% 3 Note: 1. Adjusted EBITDA is a supplemental measure of our performance that is not required by, or presented i
Slide 10: 9MO 2025 Highlights
9MO 2025 HIGHLIGHTS 9MO 2025 vs 9MO 2024 Net Revenue $657M +26% Gross Margin 73.2% +90 bps Adjusted EBITDA $151M +11% 1 Adjusted EBITDA margin 23.0% -280 bps 2 Adjusted Diluted EPS $2.00 +14% 3 Note: 1. Adjusted EBITDA is a supplemental measure of our performance that is not required by, or presente
Slide 11: Appendix
APPENDIX 11
Slide 12: Reconciliations to Adjusted Metrics
RECONCILIATIONS TO ADJUSTED METRICS U.S. dollar in thousands (except per share data) 2 3 Note: 1. Represents the tax impact of (a) the reconciling items above and (b) other discrete tax items. 2. Adjusted EBITDA is a supplemental measure of our performance that is not required by, or presented in ac
Slide 13: Reconciliations on Net Income to Adjusted EBITDA
RECONCILIATIONS ON NET INCOME TO ADJUSTED EBITDA U.S. dollar in thousands 1 Note: 1. Adjusted EBITDA is a supplemental measure of our performance that is not required by, or presented in accordance with, GAAP. Adjusted EBITDA should not be considered as an alternative to net income or any other perf
Slide 14: Reconciliation of Net Cash Provided by Operating Activities to Free Cash Flow
RECONCILIATION OF NET CASH PROVIDED BY OPERATING ACTIVITIES TO FREE CASH FLOW U.S. dollar in thousands 1 Note: 1. Free Cash Flow defined as Net Cash from Operating Activities less purchase of Property and Equipment. 14